Is there a future for 'speculative' gene patents in Europe?

被引：4

作者：

Crease, DJ ^{[1
]}

Schlich, GW ^{[1
]}

机构：

[1] Mathys & Squire Intellectual Property, London WC1X 8AL, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2003年 / 2卷 / 05期

关键词：

D O I：

10.1038/nrd1089

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In the face of increasing public opposition to patents claiming property in gene sequences, is it right to deny the validity of patent applications that seem to have firm, if somewhat hypothetical, scientific basis? In this article we review the recent state of the law in Europe as it applies to gene patents in order to determine whether there is any hope for the modern heirs of Galilean innovation.

引用

页码：407 / 410

页数：4

共 10 条

[1] Genes and patent policy: rethinking intellectual property rights [J].

Andrews, LB .

NATURE REVIEWS GENETICS, 2002, 3 (10) :803-808

[2]

[Anonymous], OFFICIAL J EUROPEA L

[3]

GONDHALEKAR P, 2001, GRIP GRAVITY

[4] From patenting genes to proteins: the search for utility via function [J].

Ilag, LL ;

Ilag, LM ;

Ilag, LL .

TRENDS IN BIOTECHNOLOGY, 2002, 20 (05) :197-199

[5] Patents and public health -: European institutions are challenging Myriad Genetics's patent monopoly on the brcal gene [J].

Lecrubier, A .

EMBO REPORTS, 2002, 3 (12) :1120-1122

[6] Diagnostic testing fails the test - The pitfalls of patents are illustrated by the case of haemochromatosis. [J].

Merz, JF ;

Kriss, AG ;

Leonard, DGB ;

Cho, MK .

NATURE, 2002, 415 (6872) :577-579

[7]

*WIPO, WIPO PUBL E, V491

[8]

2002, OFFICIAL J EPO, P293

[9]

2003, ETHICS PATENTING DNA

[10]

2002, ONTARIO DRAFT REPORT

← 1 →